Michael E Cloesmeijer

6PUBLICATIONS
9CO-AUTHORS
HaematologyPharmacogenomicsPowder and particle technologyIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 17, 2024
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space.

Michael E Cloesmeijer, Erik Sjögren, Sjoerd F Koopman

|Feb 17, 2024
Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.

Lars L F G Valke, Michael E Cloesmeijer, Hassan Mansouritorghabeh

|Aug 25, 2023
ChatGPT in pharmacometrics? Potential opportunities and limitations.

Michael E Cloesmeijer, Alexander Janssen, Sjoerd F Koopman

|May 08, 2022
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.

Jessica M Heijdra, Michael E Cloesmeijer, Nico C B de Jager

|Sep 09, 2020
Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis.

Michael E Cloesmeijer, Michiel J van Esdonk, Anne M Lynn

|Mar 10, 2020
Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics.

Michael E Cloesmeijer, Huub L A van den Oever, Ron A A Mathôt

Pageof 1